Logo image of AIL.DE

AIR LIQUIDE SA (AIL.DE) Stock Fundamental Analysis

FRA:AIL - Deutsche Boerse Ag - FR0000120073 - Common Stock - Currency: EUR

178.5  -0.06 (-0.03%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to AIL. AIL was compared to 61 industry peers in the Chemicals industry. While AIL has a great profitability rating, there are some minor concerns on its financial health. AIL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year AIL was profitable.
In the past year AIL had a positive cash flow from operations.
Each year in the past 5 years AIL has been profitable.
In the past 5 years AIL always reported a positive cash flow from operatings.
AIL.DE Yearly Net Income VS EBIT VS OCF VS FCFAIL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

The Return On Assets of AIL (6.37%) is better than 78.69% of its industry peers.
With an excellent Return On Equity value of 12.31%, AIL belongs to the best of the industry, outperforming 80.33% of the companies in the same industry.
AIL has a Return On Invested Capital of 9.63%. This is amongst the best in the industry. AIL outperforms 83.61% of its industry peers.
AIL had an Average Return On Invested Capital over the past 3 years of 9.47%. This is above the industry average of 6.81%.
The 3 year average ROIC (9.47%) for AIL is below the current ROIC(9.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.37%
ROE 12.31%
ROIC 9.63%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
AIL.DE Yearly ROA, ROE, ROICAIL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

AIL's Profit Margin of 12.22% is amongst the best of the industry. AIL outperforms 88.52% of its industry peers.
In the last couple of years the Profit Margin of AIL has grown nicely.
AIL has a better Operating Margin (19.93%) than 93.44% of its industry peers.
In the last couple of years the Operating Margin of AIL has grown nicely.
The Gross Margin of AIL (63.01%) is better than 95.08% of its industry peers.
In the last couple of years the Gross Margin of AIL has remained more or less at the same level.
Industry RankSector Rank
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
AIL.DE Yearly Profit, Operating, Gross MarginsAIL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AIL is still creating some value.
Compared to 1 year ago, AIL has about the same amount of shares outstanding.
AIL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AIL has been reduced compared to a year ago.
AIL.DE Yearly Shares OutstandingAIL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
AIL.DE Yearly Total Debt VS Total AssetsAIL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

AIL has an Altman-Z score of 3.91. This indicates that AIL is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.91, AIL belongs to the best of the industry, outperforming 83.61% of the companies in the same industry.
AIL has a debt to FCF ratio of 4.43. This is a neutral value as AIL would need 4.43 years to pay back of all of its debts.
The Debt to FCF ratio of AIL (4.43) is better than 78.69% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that AIL is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.37, AIL is doing good in the industry, outperforming 63.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 4.43
Altman-Z 3.91
ROIC/WACC1.3
WACC7.39%
AIL.DE Yearly LT Debt VS Equity VS FCFAIL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

AIL has a Current Ratio of 0.88. This is a bad value and indicates that AIL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AIL (0.88) is worse than 85.25% of its industry peers.
A Quick Ratio of 0.65 indicates that AIL may have some problems paying its short term obligations.
The Quick ratio of AIL (0.65) is worse than 85.25% of its industry peers.
AIL does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.65
AIL.DE Yearly Current Assets VS Current LiabilitesAIL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

AIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.88%, which is quite good.
AIL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.55% yearly.
The Revenue has decreased by -1.99% in the past year.
AIL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.30% yearly.
EPS 1Y (TTM)19.88%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%33.27%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%0.38%

3.2 Future

Based on estimates for the next years, AIL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.90% on average per year.
Based on estimates for the next years, AIL will show a small growth in Revenue. The Revenue will grow by 5.10% on average per year.
EPS Next Y9.9%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
EPS Next 5Y9.9%
Revenue Next Year5.5%
Revenue Next 2Y5.23%
Revenue Next 3Y5.47%
Revenue Next 5Y5.1%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AIL.DE Yearly Revenue VS EstimatesAIL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
AIL.DE Yearly EPS VS EstimatesAIL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.76, the valuation of AIL can be described as expensive.
AIL's Price/Earnings is on the same level as the industry average.
AIL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.79, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 25.26, which means the current valuation is very expensive for AIL.
AIL's Price/Forward Earnings is on the same level as the industry average.
AIL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.38.
Industry RankSector Rank
PE 27.76
Fwd PE 25.26
AIL.DE Price Earnings VS Forward Price EarningsAIL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AIL.
AIL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 36.91
EV/EBITDA 14.36
AIL.DE Per share dataAIL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AIL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.8
PEG (5Y)2.4
EPS Next 2Y10.48%
EPS Next 3Y10.45%

4

5. Dividend

5.1 Amount

AIL has a Yearly Dividend Yield of 1.85%. Purely for dividend investing, there may be better candidates out there.
AIL's Dividend Yield is comparable with the industry average which is at 3.19.
Compared to the average S&P500 Dividend Yield of 2.47, AIL is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.85%

5.2 History

The dividend of AIL has a limited annual growth rate of 5.86%.
Dividend Growth(5Y)5.86%
Div Incr Years5
Div Non Decr Years5
AIL.DE Yearly Dividends per shareAIL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

AIL pays out 51.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
AIL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.97%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
AIL.DE Yearly Income VS Free CF VS DividendAIL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
AIL.DE Dividend Payout.AIL.DE Dividend Payout, showing the Payout Ratio.AIL.DE Dividend Payout.PayoutRetained Earnings

AIR LIQUIDE SA

FRA:AIL (4/25/2025, 7:00:00 PM)

178.5

-0.06 (-0.03%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-22 2025-04-22
Earnings (Next)07-24 2025-07-24
Inst Owners27.5%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap103.25B
Analysts81.25
Price Target197.17 (10.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.85%
Yearly Dividend2.98
Dividend Growth(5Y)5.86%
DP51.97%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.11%
PT rev (3m)3.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.08%
EPS NY rev (3m)0.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 27.76
Fwd PE 25.26
P/S 3.82
P/FCF 36.91
P/OCF 16.33
P/B 3.84
P/tB 10.13
EV/EBITDA 14.36
EPS(TTM)6.43
EY3.6%
EPS(NY)7.07
Fwd EY3.96%
FCF(TTM)4.84
FCFY2.71%
OCF(TTM)10.93
OCFY6.12%
SpS46.78
BVpS46.44
TBVpS17.62
PEG (NY)2.8
PEG (5Y)2.4
Profitability
Industry RankSector Rank
ROA 6.37%
ROE 12.31%
ROCE 12.72%
ROIC 9.63%
ROICexc 10.08%
ROICexgc 17.03%
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
FCFM 10.34%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
ROICexc(3y)9.91%
ROICexc(5y)9.43%
ROICexgc(3y)16.92%
ROICexgc(5y)16.28%
ROCE(3y)12.5%
ROCE(5y)11.85%
ROICexcg growth 3Y3.94%
ROICexcg growth 5Y3.85%
ROICexc growth 3Y4.91%
ROICexc growth 5Y4.63%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 4.43
Debt/EBITDA 1.25
Cap/Depr 140.72%
Cap/Sales 13.03%
Interest Coverage 20.46
Cash Conversion 80.06%
Profit Quality 84.6%
Current Ratio 0.88
Quick Ratio 0.65
Altman-Z 3.91
F-Score8
WACC7.39%
ROIC/WACC1.3
Cap/Depr(3y)136.72%
Cap/Depr(5y)133.49%
Cap/Sales(3y)12.08%
Cap/Sales(5y)12.32%
Profit Quality(3y)89.93%
Profit Quality(5y)95.75%
High Growth Momentum
Growth
EPS 1Y (TTM)19.88%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%33.27%
EPS Next Y9.9%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
EPS Next 5Y9.9%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%0.38%
Revenue Next Year5.5%
Revenue Next 2Y5.23%
Revenue Next 3Y5.47%
Revenue Next 5Y5.1%
EBIT growth 1Y6.38%
EBIT growth 3Y9.02%
EBIT growth 5Y7.28%
EBIT Next Year61.21%
EBIT Next 3Y23.37%
EBIT Next 5Y16.13%
FCF growth 1Y-2.53%
FCF growth 3Y1.77%
FCF growth 5Y6.15%
OCF growth 1Y0.95%
OCF growth 3Y4.31%
OCF growth 5Y6.05%